Effects of mTOR inhibition on cardiac and adipose tissue pathology and glucose metabolism in rats with metabolic syndrome

The mammalian target of rapamycin (mTOR) is a regulator of metabolism and is implicated in pathological conditions such as obesity and diabetes. We aimed to investigate the role of mTOR in obesity. A new animal model of metabolic syndrome (MetS), named DahlS.Z‐Lepr (fa)/Lepr (fa) (DS/obese) rats was...

Descripción completa

Detalles Bibliográficos
Autores principales: Uchinaka, Ayako, Yoneda, Mamoru, Yamada, Yuichiro, Murohara, Toyoaki, Nagata, Kohzo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5684863/
https://www.ncbi.nlm.nih.gov/pubmed/28805979
http://dx.doi.org/10.1002/prp2.331

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5684863/
https://www.ncbi.nlm.nih.gov/pubmed/28805979
http://dx.doi.org/10.1002/prp2.331

Ejemplares similares